|
Name |
2-Octyldecyl propionate
|
| Molecular Formula | C21H42O2 | |
| IUPAC Name* |
2-octyldecyl propanoate
|
|
| SMILES |
CCCCCCCCC(CCCCCCCC)COC(=O)CC
|
|
| InChI |
InChI=1S/C21H42O2/c1-4-7-9-11-13-15-17-20(19-23-21(22)6-3)18-16-14-12-10-8-5-2/h20H,4-19H2,1-3H3
|
|
| InChIKey |
WNRAEXUQVUIIFS-UHFFFAOYSA-N
|
|
| Synonyms |
2-Octyldecyl propionate
|
|
| CAS | NA | |
| PubChem CID | 91693215 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 326.6 | ALogp: | 9.1 |
| HBD: | 0 | HBA: | 2 |
| Rotatable Bonds: | 18 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
| Heavy Atoms: | 23 | QED Weighted: | 0.212 |
| Caco-2 Permeability: | -4.76 | MDCK Permeability: | 0.00001250 |
| Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.941 |
| 30% Bioavailability (F30%): | 0.996 |
| Blood-Brain-Barrier Penetration (BBB): | 0.048 | Plasma Protein Binding (PPB): | 97.44% |
| Volume Distribution (VD): | 2.553 | Fu: | 1.36% |
| CYP1A2-inhibitor: | 0.174 | CYP1A2-substrate: | 0.194 |
| CYP2C19-inhibitor: | 0.391 | CYP2C19-substrate: | 0.069 |
| CYP2C9-inhibitor: | 0.136 | CYP2C9-substrate: | 0.847 |
| CYP2D6-inhibitor: | 0.537 | CYP2D6-substrate: | 0.051 |
| CYP3A4-inhibitor: | 0.421 | CYP3A4-substrate: | 0.09 |
| Clearance (CL): | 5.57 | Half-life (T1/2): | 0.156 |
| hERG Blockers: | 0.318 | Human Hepatotoxicity (H-HT): | 0.024 |
| Drug-inuced Liver Injury (DILI): | 0.33 | AMES Toxicity: | 0.003 |
| Rat Oral Acute Toxicity: | 0.018 | Maximum Recommended Daily Dose: | 0.025 |
| Skin Sensitization: | 0.956 | Carcinogencity: | 0.052 |
| Eye Corrosion: | 0.955 | Eye Irritation: | 0.958 |
| Respiratory Toxicity: | 0.756 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000626 | ![]() |
0.623 | D00MLW | ![]() |
0.490 | ||
| ENC000813 | ![]() |
0.614 | D07ILQ | ![]() |
0.471 | ||
| ENC001143 | ![]() |
0.608 | D0T9TJ | ![]() |
0.442 | ||
| ENC001234 | ![]() |
0.603 | D0O1PH | ![]() |
0.440 | ||
| ENC003079 | ![]() |
0.596 | D0Z5SM | ![]() |
0.434 | ||
| ENC001236 | ![]() |
0.587 | D05ATI | ![]() |
0.418 | ||
| ENC001202 | ![]() |
0.587 | D00FGR | ![]() |
0.414 | ||
| ENC001218 | ![]() |
0.578 | D00AOJ | ![]() |
0.389 | ||
| ENC000968 | ![]() |
0.569 | D0X4FM | ![]() |
0.373 | ||
| ENC000422 | ![]() |
0.567 | D0P1RL | ![]() |
0.360 | ||